ENVI GREEN-LIGHTS COMPROMISE ON CLINICAL TRIALS.

• Position: Committee on the Environment and Public Health - Brief article

On 22 January, the European Parliament's Committee on the Environment and Public Health (ENVI) approved the compromise that was negotiated with the Council on the regulation on clinical trials on medicinal products for human use. The document, which revokes Directive 2001/20/EC, aims to make it quicker and easier to authorise research into the effects of a drug, all the while maintaining high standards to ensure the patients' safety. The document arranges for pharmaceutical companies and university researchers to transfer results from their clinical trials into a database that is accessible to the public. This database will be managed by the...